To define a potential protective or favouring role of CRBPI in the development of psoriatic lesions, we investigated imiquimod-induced back skin inflammation, a well-known experimental model of psoriasis [17, 18] induced in CRBPI-knockout and wild-type C57BL/6 mice. Here, RBP1 is linked to psoriasis.